MetLife price target lowered to $94 from $109 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on MetLife (MET) to $94 from $109 and keeps an Overweight rating on the shares. On average across the firm’s life insurance coverage, Q1 EPS estimates declined 3% from prior estimates and its 2025 EPS estimates declined 4% from prior estimates, though results vary across companies, notes the analyst in a preview for the group. For underwriting-oriented companies that should not be as sensitive to equity market fluctuations, the firm’s estimates generally did not change as much, but it still moved underwriter estimates down as they likely face an incrementally more challenging operating environment, the analyst noted.